Oxalic Acid

Oxalic Acid

SCHEMBL4354000

CN1CCN[C@@H](c2ccccc2)C1.O=C(O)C(=O)O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 2/20 0.43
RPS6KB1 P23443 1/20 0.45
GSK3B P49841 2/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A3 Q01959 2/20 0.43
PDE10A Q9Y233 1/20 0.41
PRKCQ Q04759 2/20 0.40
NAPEPLD Q6IQ20 1/20 0.40
POLB P06746 1/20 0.39
EPHX2 P34913 1/20 0.38
CYP2D6 P10635 1/20 0.38
HTT P42858 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM3 P20309 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL4354003 1.00 RPS6KB1 (0.45) RPS6KB1GSK3BSLC6A2SLC6A4SLC6A3
SCHEMBL2908444 0.92 PDE10A (0.45) RPS6KB1GSK3BSLC6A2SLC6A4SLC6A3
SCHEMBL90572 0.92 PDE10A (0.45) RPS6KB1GSK3BSLC6A2SLC6A4SLC6A3
SCHEMBL2910280 0.92 PDE10A (0.45) RPS6KB1GSK3BSLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL27510131 0.90 GSK3B (0.45) RPS6KB1GSK3BSLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL10626673 0.90 GSK3B (0.45) RPS6KB1GSK3BSLC6A2SLC6A4SLC6A3
SCHEMBL2913625 0.89 SLC6A2 (0.40) RPS6KB1GSK3BSLC6A2SLC6A4SLC6A3
SCHEMBL27765904 0.89 SLC6A2 (0.46) RPS6KB1GSK3BSLC6A2SLC6A4SLC6A3
SCHEMBL2911012 0.87 NAPEPLD (0.41) RPS6KB1GSK3BSLC6A2SLC6A4SLC6A3
SCHEMBL27744984 0.86 L3MBTL1 (0.42) RPS6KB1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275749-A1 PRODUCTION METHOD OF OPTICALLY ACTIVE PIPERAZINE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-11-05 US disclosed
EP-1930325-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE PIPERAZINE COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-06-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275749-A1 PRODUCTION METHOD OF OPTICALLY ACTIVE PIPERAZINE COMPOUND CYP51A1, CYP4Z1, CYP4A11 SLC6A4 113/4885RPS6KB1 502/4885GSK3B 876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.